What is Pulmonics Plus?
Pulmonics Plus operates at the intersection of advanced respiratory medicine and patient-centric outpatient care. By providing a comprehensive suite of services ranging from hospital consultative care to specialized sleep disorder treatments, the firm has established itself as a critical provider in the healthcare landscape. Their clinical team utilizes evidence-based protocols to manage complex respiratory diseases, ensuring that patients receive personalized, high-acuity care in a supportive, accessible environment. This market position is bolstered by a commitment to patient education and the integration of advanced diagnostic tools, which collectively drive superior health outcomes and operational efficiency.
How much funding has Pulmonics Plus raised?
Pulmonics Plus has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pulmonics Plus
PPP
Public-Private Partnership
What's next for Pulmonics Plus?
With the influx of capital from this late-stage funding, Pulmonics Plus is poised to accelerate its expansion strategy. The organization is expected to prioritize the scaling of its outpatient facilities and the enhancement of its consultative service network. By leveraging this financial backing, the company aims to deepen its market penetration in the respiratory and sleep medicine sectors, potentially integrating new digital health technologies to streamline patient monitoring and treatment adherence. This strategic growth phase will likely focus on optimizing clinical workflows and expanding the reach of their specialized care teams to meet the rising demand for chronic respiratory disease management.
See full Pulmonics Plus company page
